溶栓治疗在急性心肌梗死中的疗效观察

Efficacy Dbservation on Acute Myocardial Infarction by Thrombolysis Treatment

目的:探讨临床应用葡激酶静脉溶栓治疗急性心肌梗死的疗效。方法:分析124例符合WHO规定的AMI诊断标准的患者行葡激酶静脉溶栓治疗的疗效。结果:实验组治疗后1h内再通21例占33.87%,生存率79.03%;对照组治疗后1h内再通4例,生存率32.26%。两组比较有显著性差异(P<0.05)。结论:AMI溶栓治疗越早,再通率就越高,能更大程度地改善心功能,缩小梗死面积,提高存活率。

Objective：To evaluate the clinical application of staphylokinase intravenous thrombolysis for acute myocardial infarction. Methods：124 cases by provisions in line with WHO diagnostic criteria for AMI patients with intravenous thrombolytie therapy staphylokinase,analyze its effectiveness.Results：The experimental group were treated within 1 hour after reperfusion in 21 cases, accounting for 33.87%,79.03% survival rate in the control group after treatment within 1 hour recanalization in 4 cases,survival rate was 32.26% ,the difference significant,P 〈0.05.Condusion：AMI patients with thrombolytic therapy the more the higher the earlier the recanalization rate,can a greater degree of improvement in cardiac function, reduce infarct size and improve survival.